Study questions accuracy of genetic test for opioid use disorder

Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, with more than 6 million Americans aged 12 and older meeting the criteria for OUD in 2022.

Bayer buys European rights to BridgeBio’s ATTR-CM pill

As Bayer undergoes a major strategy rethink, with a full-year 2023 update slated for Tuesday, the conglomerate is enlisting external help to boost its cardio

March 5, 2024

Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases – Biotech Investments

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases 14.12.2023 / 07:30 CET/CEST The

December 15, 2023

WHO updates Bacterial Priority Pathogens List to combat antimicrobial resistance

The World Health Organization (WHO) today released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria grouped into critical, high

May 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.